Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma

Chari, A; Vogl, DT; Gavriatopoulou, M; Nooka, AK; Yee, AJ; Huff, CA; Moreau, P; Dingli, D; Cole, C; Lonial, S; Dimopoulos, M; Stewart, AK; Richter, J; Vij, R; Tuchman, S; Raab, MS; Weisel, KC; Delforge, M; Cornell, RF; Kaminetzky, D; Hoffman, JE; Cos

Jagannath, S (reprint author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, 1470 Madison Ave,3rd Fl, New York, NY 10029 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 381 (8): 727

Abstract

BackgroundSelinexor, a selective inhibitor of nuclear export compound that blocks exportin 1 (XPO1) and forces nuclear accumulation and activation of ......

Full Text Link